No Data
Here's What's Concerning About Veeva Systems' (NYSE:VEEV) Returns On Capital
Wells Fargo Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $242
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED), Avidity Biosciences (RNA) and Veeva Systems (VEEV)
Buy Rating for Veeva Systems: Strategic CFO Appointment and Strong Market Position Fuel Upside Potential
Veeva Systems Inc.'s (NYSE:VEEV) Intrinsic Value Is Potentially 57% Above Its Share Price
Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit